Sign in
Active, not recruitingNo phase

Use of Cannabis Oil in Fibromyalgia

Key facts

Who runs it
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
65 people enrolled
Started
19 Oct 2024
Ended
31 Dec 2025
Type of study
Observational
Treatments tested
  • Use of cannabis oil
Record updated
26 September 2025

Who can take part

Age
21 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • written informed consent
  • age ≥ 21 years
  • diagnosis of FM according to the 2016 American College of Rheumatology (ACR) diagnostic criteria
  • failure of previous therapies

Who cannot take part

  • psychiatric disorders,
  • history of drug or alcohol addiction,
  • fatty liver disease or severe liver disease,
  • severe cardiopulmonary disease,
  • severe renal failure,
  • pregnancy or breastfeeding

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Recently, medical cannabis has been shown to be effective in chronic pain conditions such as osteoarthritis, neuropathic pain, and other chronic non-cancer pain.

Read full original descriptionShow less

A study showed that fibromyalgia patients who use cannabis report significant improvement in pain symptoms and quality of life. Patients reported a 50% reduction in pain, and many also reported improvements in sleep and overall well-being. Further research found that the use of medical cannabis among patients with fibromyalgia led to significant improvements in pain, sleep quality, and overall quality of life. This study emphasized that adverse effects were generally mild and tolerable. Furthermore, the systematic review by Fitz et al. concluded that cannabis may be effective in treating fibromyalgia, with preliminary evidence indicating improvements in pain and sleep disturbances. However, it also highlighted the need for further randomized controlled trials to confirm these findings and determine how the cannabinoid system interacts with the pain pathway.

Considering that medical cannabis is effective in treating a variety of symptoms, including pain, cachexia and wasting, sleep disorders, severe or persistent muscle spasms, reduced fatigue in multiple sclerosis, chemotherapy-induced nausea, convulsive disorders, post-traumatic stress disorder, and other conditions in palliative and end-of-life care; with this study, given the premises of the effects of medical cannabis, the aim is to analyze its use also in chronic pain as the main symptom of fibromyalgia syndrome.

Treatments tested

  • Use of cannabis oil

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Evaluation of the Use of Cannabis Oil in Patients With Fibromyalgia
Record updated
26 September 2025